DiaSorin and MeMed Get CE Mark for Liaison MeMed BV Blood Test

DiaSorin and MeMed have earned a CE mark for their Liaison MeMed BV, an automated diagnostic test that enables physicians to differentiate between bacterial and viral infections.

DiaSorin entered into a licensing agreement with MeMed in September 2020, gaining the rights to make the MeMed BV test available on its Liaison XL chemiluminescence analyzers and Liaison XS software platforms.

DiaSorin plans to seek the FDA’s 510(k) clearance for the assay in 2022.